Jessica Kirchman
Family · Okeechobee, FLNPI 1144950882
Payments from drug & device makers
Across 99 payments — averaging $19.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$303
- Bayer$250
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$200
- Boehringer Ingelheim$168
- GSK$151
- Lilly USA, LLC$112
- plus $751 from 18 others
What the payments were for
- Food & beverage$1,86997%
- Education$663%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 21 | $303 |
| Bayer | 9 | $250 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $200 |
| Boehringer Ingelheim | 7 | $168 |
| GSK | 9 | $151 |
| Lilly USA, LLC | 7 | $112 |
| Pfizer | 5 | $92 |
| Novo Nordisk | 5 | $85 |
| Sanofi-aventis U.S. LLC | 3 | $66 |
| Astellas Pharma US Inc | 1 | $66 |
| Almatica Pharma LLC | 3 | $66 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $63 |
| Sumitomo Pharma America, Inc. | 3 | $62 |
| Dexcom, Inc. | 2 | $43 |
| Merck | 2 | $31 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Sunovion Pharmaceuticals Inc. | 1 | $28 |
| AstraZeneca | 1 | $23 |
| Exact Sciences | 1 | $19 |
| Amgen | 1 | $18 |
| Johnson & Johnson | 1 | $17 |
| Novartis | 1 | $16 |
| Lundbeck LLC | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,935 in reported general payments places this provider in the 80th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 39 | $53,021 |
| OzempicSemaglutide | 37 | $47,907 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 28 | $34,788 |
| EliquisApixaban | 23 | $27,456 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 15 | $16,649 |
| PaxlovidNirmatrelvir/Ritonavir | 25 | $4,288 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 56 | $1,981 |
| Methylprednisolone | 226 | $1,363 |
| Azithromycin | 140 | $1,153 |
| Gabapentin | 72 | $849 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 102 | $817 |
| Testosterone Cypionate | 17 | $790 |
| Atorvastatin Calcium | 80 | $638 |
| Metoprolol Succinate | 46 | $595 |
| Tizanidine Hcl | 43 | $532 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $112 | $53,02139 claims |
| Novo NordiskOzempic | $85 | $47,90737 claims |
| GSKTrelegy Ellipta | $151 | $34,78828 claims |
| PfizerEliquis, Paxlovid | $92 | $31,74448 claims |
| AstraZenecaBreztri Aerosphere | $23 | $16,64915 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 14,618 family providers in Florida.
Other family in Okeechobee
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
- David RodriguezHialeah$658K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.